Tag: ImmunoOncology

spot_imgspot_img

Imugene: Receives $4.8M tax rebate on cancer research

Clinical-stage immuno-oncology company Imugene (IMU) has received a hefty tax rebate for its research and development (R&D) spending The company has banked a...

Imugene: Receives FDA approval for PD1-Vaxx trial

Imugene (IMU) has received approval from the U.S. Food and Drug Administration (FDA) to begin a clinical trial for its PD1-Vaxx drug Then...